Replies to post #60718 on Anavex Life Sciences Corp (AVXL)

[ClosetInvestor]

That's what I meant to say! One of the important aspects of the trial design is that the FDA has been giving their guidance, which is key. If and when the phase 2/3 results are good, the FDA will again, if needed, assist in designing the most efficient trial to get 2-73 to market.